Loading…
Based on limited metadata, Pure Nootropics, LLC received an FDA Warning Letter on February 5, 2019, regarding their dietary supplement products. Without access to the full letter text or subject line, the specific nature of the violations cannot be definitively characterized, though they likely relate to manufacturing, labeling, marketing claims, or ingredient compliance issues common to dietary supplement enforcement actions. The warning falls under FDA's dietary supplement regulatory authority. Additional documentation would be needed to identify the precise compliance concerns cited in this enforcement action.